Training data from https://doi.org/10.1039/C8SC04228D (8/10) · 10.1039/C8SC04228D
查看IDENTITY
结构与身份
- 标准SMILES
- Cc1nc(Nc2ccc(F)cc2)nc(N2CCc3ccccc3C2C)c1C
- InChIKey
- LECZXZOBEZITCL-UHFFFAOYSA-N
- 分子式
- C22H23FN4
- 平均分子量
- 362.4 g/mol
- 单同位素质量
- 362.19067491
COMPUTED
结构计算性质
- XLogP
- 5.3
- 极性表面积
- 41.1 Ų
- 氢键供体
- 1
- 氢键受体
- 5
- 可旋转键
- 3
- 重原子
- 27
- 形式电荷
- 0
- 复杂度
- 481
ALIASES
名称与别名
Revaprazan199463-33-7RevanexYH-1885 FREE BASESB-6412575P184180P5REVAPRAZANUMRefChem:179017Revaprazan [INN]N-(4-Fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)pyrimidin-2-amine4-(3,4-dihydro-1-methyl-2(1h)-isoquinolinyl)-n-(4-fluorophenyl)-5,6-dimethyl-2-pyrimidinamineN-(4-fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-1H-isoquinolin-2-yl)pyrimidin-2-amineN-(4-FLUOROPHENYL)-4,5-DIMETHYL-6-[(1S)-1-METHYL-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL]PYRIMIDIN-2-AMINEUNII-5P184180P5199463-33-7 (free base)MFCD26405757REVAPRAZAN [MI]SB 641257REVAPRAZAN [MART.]REVAPRAZAN [WHO-DD]
REACTIONS
相关反应
Training data from https://doi.org/10.1039/C8SC04228D (8/10) · 10.1039/C8SC04228D
查看Training data from https://doi.org/10.1039/C8SC04228D (3/10) · 10.1039/C8SC04228D
查看uspto-grants-2001_06 · 10.6084/m9.figshare.5104873.v1 · US06252076B1
查看uspto-grants-2001_06 · 10.6084/m9.figshare.5104873.v1 · US06252076B1
查看uspto-grants-2001_06 · 10.6084/m9.figshare.5104873.v1 · US06252076B1
查看uspto-grants-2001_06 · 10.6084/m9.figshare.5104873.v1 · US06252076B1
查看uspto-grants-2001_06 · 10.6084/m9.figshare.5104873.v1 · US06252076B1
查看